Sydney:12/24 22:26:56

Tokyo:12/24 22:26:56

Hong Kong:12/24 22:26:56

Singapore:12/24 22:26:56

Dubai:12/24 22:26:56

London:12/24 22:26:56

New York:12/24 22:26:56

Live Updates  >  Live Update Details

2026-09-16 02:05:13

Contineum's stock price plummeted 9.9%, triggered by the failure of an interim clinical trial for an antidepressant drug developed in partnership with Johnson & Johnson. This clinical trial setback directly impacted market expectations for the commercialization of the investigational antidepressant and dampened investor confidence in Contineum's future development pipeline, ultimately leading to significant stock price volatility.

Real-Time Popular Commodities

Instrument Current Price Change

XAU

4341.92

-36.37

(-0.83%)

XAG

65.975

-0.271

(-0.41%)

CONC

92.04

-4.04

(-4.20%)

OILC

100.11

-3.08

(-2.99%)

USD

100.414

0.204

(0.20%)

EURUSD

1.1465

-0.0020

(-0.17%)

GBPUSD

1.3369

-0.0024

(-0.18%)

USDCNH

6.6925

-0.0021

(-0.03%)

Hot News